Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for initial treatment of acute mania
2010-023992-24Phase 3Completed
- Sponsor
- Leipzig University
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar disorder (BD), mania and hypomania comparing Methylphenidate immediate-release BID with Placebo BID (2 arms). Primary endpoint: Change in manic symptoms after 2.5 days. Started May 2011; status: completed.
02
Drugs
methylphenidate
03
Conditions
bipolar disorder (BD)maniahypomania
Beyond the preview
Go deeper on 2010-023992-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023992-24.